|
US951A
(en)
|
|
1838-09-27 |
|
Improvement in the mode of extracting color from dye-woods |
|
US6358A
(en)
|
|
1849-04-17 |
|
Grate for coal-stoves |
|
US2530570A
(en)
*
|
|
1950-11-21 |
|
Pyrimidylmercapto-carboxylic acids |
|
US2263702A
(en)
|
1939-01-18 |
1941-11-25 |
Konstruktion Und Verwertung Au |
Centrifugal clutch construction
|
|
US3980781A
(en)
|
1966-03-31 |
1976-09-14 |
Imperial Chemical Industries Limited |
Fungicidal composition and method containing 2-amino-pyrimidines
|
|
US4062950A
(en)
|
1973-09-22 |
1977-12-13 |
Bayer Aktiengesellschaft |
Amino sugar derivatives
|
|
US3914250A
(en)
|
1974-08-01 |
1975-10-21 |
American Home Prod |
1,4-Diazepino{8 6,5,4-jk{9 carbazoles
|
|
JPS608117B2
(ja)
|
1977-02-08 |
1985-02-28 |
財団法人微生物化学研究会 |
新生理活性物質エステラスチンおよびその製造法
|
|
DE2719912C3
(de)
|
1977-05-04 |
1979-12-06 |
Bayer Ag, 5090 Leverkusen |
Verfahren zur Isolierung von 0- |4,6-Dideoxy-4- [JJl S-O,4,6/5)-4,5,6-trihydroxy-3-hydroxymethyl-2cyclohexen-1-yl] -amino] - a -D-glucopyranosyl} -(I Pfeil nach rechts 4)-0- a D-glucopyranosyl-(l Pfeil nach rechts 4)-D-glucopyranose aus Kulturbrühen
|
|
NO154918C
(no)
|
1977-08-27 |
1987-01-14 |
Bayer Ag |
Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
|
|
JPS5953920B2
(ja)
|
1977-12-28 |
1984-12-27 |
東洋醸造株式会社 |
新規なアミノ糖化合物およびその製法
|
|
CA1121290A
(en)
|
1978-02-14 |
1982-04-06 |
Yasuji Suhara |
Amino sugar derivatives
|
|
DE2928485A1
(de)
|
1979-07-14 |
1981-01-29 |
Bayer Ag |
Verwendung von harnstoffderivaten als arzneimittel bei der behandlung von fettstoffwechselstoerungen
|
|
ES505959A0
(es)
|
1980-10-09 |
1982-09-01 |
Hoechst Ag |
Procedimiento para la preparacion de un inactivador de alfa-amilasa
|
|
DE3166093D1
(en)
|
1981-01-05 |
1984-10-18 |
Takeda Chemical Industries Ltd |
N-substituted pseudo-aminosugars, their production and use
|
|
ZA821577B
(en)
|
1981-04-06 |
1983-03-30 |
Boots Co Plc |
Therapeutic agents
|
|
US4452813A
(en)
|
1981-05-22 |
1984-06-05 |
Taiho Pharmaceutical Company Limited |
Sulfonate derivatives, process for preparing same and antilipemic compositions containing the derivative
|
|
US4577376A
(en)
|
1982-01-01 |
1986-03-25 |
Clendinen Charles D |
Snap fastener
|
|
CA1247547A
(en)
|
1983-06-22 |
1988-12-28 |
Paul Hadvary |
Leucine derivatives
|
|
FR2549984B1
(fr)
|
1983-07-29 |
1985-10-18 |
Telediffusion Fse |
Systeme de correction d'erreurs de signaux numeriques codes en code de reed-solomon
|
|
DK520784A
(da)
|
1984-01-21 |
1985-07-22 |
Hoechst Ag |
Cycliske polypeptider, deres fremstilling og anvendelse
|
|
US4634765A
(en)
|
1984-12-18 |
1987-01-06 |
Merrell Dow Pharmaceuticals Inc. |
Homodisaccharide hypoglycemic agents
|
|
US4751237A
(en)
|
1986-01-27 |
1988-06-14 |
Merck & Co., Inc. |
Antihypercholesterolemic beta-lactones
|
|
US4847271A
(en)
|
1986-01-27 |
1989-07-11 |
Merck & Co., Inc. |
Antihypercholesterolemic β-lactones
|
|
US4816477A
(en)
|
1987-05-26 |
1989-03-28 |
Merck & Co., Inc. |
Antihypercholesterolemic β-lactones
|
|
US4806564A
(en)
|
1987-05-26 |
1989-02-21 |
Merck & Co., Inc. |
Antihypercholesterolemic beta-lactones
|
|
NZ227042A
(en)
|
1987-11-27 |
1991-05-28 |
Banyu Pharma Co Ltd |
Substituted alkylamine derivatives and pharmaceutical compositions
|
|
US5192772A
(en)
|
1987-12-09 |
1993-03-09 |
Nippon Shinyaku Co. Ltd. |
Therapeutic agents
|
|
US4919602A
(en)
|
1987-12-21 |
1990-04-24 |
Janszen Arthur W |
Apparatus for repairing windshields
|
|
EP0344383A1
(en)
|
1988-06-02 |
1989-12-06 |
Merrell Dow Pharmaceuticals Inc. |
Novel alpha-Glucosidase inhibitors
|
|
DE3836675A1
(de)
|
1988-10-28 |
1990-05-03 |
Hoechst Ag |
Glykosidase-inhibitor salbostatin, verfahren zu seiner herstellung und seine verwendung
|
|
IE61928B1
(en)
|
1988-11-29 |
1994-11-30 |
Boots Co Plc |
Treatment of obesity
|
|
JPH02169571A
(ja)
|
1988-12-22 |
1990-06-29 |
Banyu Pharmaceut Co Ltd |
置換アリルアミン誘導体
|
|
US5064856A
(en)
|
1989-07-31 |
1991-11-12 |
Merck & Co., Inc. |
Novel hmg-coa synthase inhibitors
|
|
US4983597A
(en)
|
1989-08-31 |
1991-01-08 |
Merck & Co., Inc. |
Beta-lactams as anticholesterolemic agents
|
|
US5391571A
(en)
|
1989-11-15 |
1995-02-21 |
American Home Products Corporation |
Cholesterol ester hydrolase inhibitors
|
|
US5112820A
(en)
|
1990-03-05 |
1992-05-12 |
Sterling Drug Inc. |
Anti-glaucoma compositions containing 2- and 3-aminomethyl-6-arylcarbonyl- or 6-phenylthio-2,3-dihydropyrrolo-(1,2,3-de)-1,4-benzoxazines and method of use thereof
|
|
US5081122A
(en)
|
1990-03-05 |
1992-01-14 |
Sterling Drug Inc. |
Antiglaucoma compositions containing 4-arylcarbonyl-1-(4-morpholinyl)-lower-alkyl)-1H-indoles and method of use thereof
|
|
US4973587A
(en)
|
1990-03-08 |
1990-11-27 |
Sterling Drug Inc. |
3-arylcarbonyl-1-aminoalkyl-1H-indole-containing antiglaucoma method
|
|
US5013837A
(en)
|
1990-03-08 |
1991-05-07 |
Sterling Drug Inc. |
3-Arylcarbonyl-1H-indole-containing compounds
|
|
US5504078A
(en)
|
1990-06-08 |
1996-04-02 |
Merrell Dow Pharmaceuticals Inc. |
α-glucosidase inhibitors
|
|
US5120729A
(en)
|
1990-06-20 |
1992-06-09 |
Merck & Co., Inc. |
Beta-lactams as antihypercholesterolemics
|
|
US5091418A
(en)
|
1990-09-28 |
1992-02-25 |
Bristol-Myers Squibb Company |
Novel alpha-glucosidase inhibitor, pradimicin Q
|
|
US5217877A
(en)
|
1990-09-28 |
1993-06-08 |
Bristol-Myers Squibb Company |
Process for the preparation of α-glucosidase inhibitor, pradimicin Q
|
|
US5182298A
(en)
|
1991-03-18 |
1993-01-26 |
Merck & Co., Inc. |
Cholesterol lowering agents
|
|
FR2692575B1
(fr)
|
1992-06-23 |
1995-06-30 |
Sanofi Elf |
Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
|
|
US6472178B1
(en)
|
1998-02-27 |
2002-10-29 |
Regeneron Pharmaceuticals, Inc. |
Nucleic acids encoding a modified ciliary neurotrophic factor and method of making thereof
|
|
US5349056A
(en)
|
1992-10-09 |
1994-09-20 |
Regeneron Pharmaceuticals |
Modified ciliary neurotrophic factors
|
|
US5451677A
(en)
|
1993-02-09 |
1995-09-19 |
Merck & Co., Inc. |
Substituted phenyl sulfonamides as selective β 3 agonists for the treatment of diabetes and obesity
|
|
US5292736A
(en)
|
1993-02-26 |
1994-03-08 |
Sterling Winthrop Inc. |
Morpholinoalkylindenes as antiglaucoma agents
|
|
FR2714057B1
(fr)
|
1993-12-17 |
1996-03-08 |
Sanofi Elf |
Nouveaux dérivés du 3-pyrazolecarboxamide, procédé pour leur préparation et compositions pharmaceutiques les contenant.
|
|
US5705515A
(en)
|
1994-04-26 |
1998-01-06 |
Merck & Co., Inc. |
Substituted sulfonamides as selective β-3 agonists for the treatment of diabetes and obesity
|
|
WO1996014307A1
(en)
|
1994-11-07 |
1996-05-17 |
Pfizer Inc. |
Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands
|
|
US5559208A
(en)
|
1995-01-31 |
1996-09-24 |
Eli Lilly And Company |
Anti-obesity proteins
|
|
US5521283A
(en)
|
1995-01-31 |
1996-05-28 |
Eli Lilly And Company |
Anti-obesity proteins
|
|
US5605886A
(en)
|
1995-01-31 |
1997-02-25 |
Eli Lilly And Company |
Anti-obesity proteins
|
|
US5552523A
(en)
|
1995-01-31 |
1996-09-03 |
Eli Lilly And Company |
Anti-obesity proteins
|
|
JPH11501297A
(ja)
|
1995-01-31 |
1999-02-02 |
イーライ・リリー・アンド・カンパニー |
抗肥満症タンパク質
|
|
US5552522A
(en)
|
1995-01-31 |
1996-09-03 |
Eli Lilly And Company |
Anti-obesity proteins
|
|
EP0725079A1
(en)
|
1995-01-31 |
1996-08-07 |
Eli Lilly And Company |
Anti-obesity proteins
|
|
US5552524A
(en)
|
1995-01-31 |
1996-09-03 |
Eli Lilly And Company |
Anti-obesity proteins
|
|
US5554727A
(en)
|
1995-01-31 |
1996-09-10 |
Eli Lilly And Company |
Anti-obesity proteins
|
|
US5532237A
(en)
|
1995-02-15 |
1996-07-02 |
Merck Frosst Canada, Inc. |
Indole derivatives with affinity for the cannabinoid receptor
|
|
US5831115A
(en)
|
1995-04-21 |
1998-11-03 |
Abbott Laboratories |
Inhibitors of squalene synthase and protein farnesyltransferase
|
|
US20020006964A1
(en)
|
1995-05-16 |
2002-01-17 |
Young James W. |
Methods of using and compositions comprising (+) sibutramine optionally in combination with other pharmacologically active compounds
|
|
US5739106A
(en)
|
1995-06-07 |
1998-04-14 |
Rink; Timothy J. |
Appetite regulating compositions
|
|
FR2741621B1
(fr)
|
1995-11-23 |
1998-02-13 |
Sanofi Sa |
Nouveaux derives de pyrazole, procede pour leur preparation et compositions pharmaceutiques en contenant
|
|
AU7692996A
(en)
|
1995-12-01 |
1997-06-27 |
Ciba-Geigy Ag |
Receptor antagonists
|
|
WO1997020822A1
(en)
|
1995-12-01 |
1997-06-12 |
Novartis Ag |
Quinazolin-2,4-diazirines as npy receptor antagonist
|
|
WO1997020821A1
(en)
|
1995-12-01 |
1997-06-12 |
Novartis Ag |
Heteroaryl derivatives
|
|
AU7626496A
(en)
|
1995-12-01 |
1997-06-27 |
Ciba-Geigy Ag |
Heteroaryl compounds
|
|
AU1328197A
(en)
|
1995-12-01 |
1997-06-19 |
Synaptic Pharmaceutical Corporation |
Aryl sulfonamide and sulfamide derivatives and uses thereof
|
|
TW432073B
(en)
|
1995-12-28 |
2001-05-01 |
Pfizer |
Pyrazolopyridine compounds
|
|
CA2244831A1
(en)
|
1996-02-02 |
1997-08-07 |
John T. Olson |
Method of treating diabetes and related disease states
|
|
ATE236137T1
(de)
|
1996-02-02 |
2003-04-15 |
Merck & Co Inc |
Heterocyclische verbindungen als antidiabetische mittel und für die behandlung von fettleibigkeit
|
|
JP2002503202A
(ja)
|
1996-02-02 |
2002-01-29 |
メルク エンド カンパニー インコーポレーテッド |
抗糖尿病薬
|
|
CA2245524A1
(en)
|
1996-02-02 |
1997-08-07 |
Wei Han |
Antidiabetic agents
|
|
US6017919A
(en)
|
1996-02-06 |
2000-01-25 |
Japan Tobacco Inc. |
Compounds and pharmaceutical use thereof
|
|
IT1288388B1
(it)
|
1996-11-19 |
1998-09-22 |
Angeletti P Ist Richerche Bio |
Uso di sostanze che attivano il recettore del cntf ( fattore neurotrofico ciliare) per la preparazione di farmaci per la terapia
|
|
DE69729315T2
(de)
|
1996-12-16 |
2005-06-23 |
Banyu Pharmaceutical Co., Ltd. |
Aminopyrazolderivate
|
|
JPH10237049A
(ja)
|
1996-12-24 |
1998-09-08 |
Nippon Chemiphar Co Ltd |
ベンズイソキサゾ−ル誘導体
|
|
JP4798814B2
(ja)
|
1997-01-07 |
2011-10-19 |
アミリン・ファーマシューティカルズ，インコーポレイテッド |
食物摂取低減用のエキセンジンおよびそのアゴニストの使用
|
|
CA2278307A1
(en)
|
1997-01-21 |
1998-07-23 |
Siegfried Benjamin Christensen Iv |
Novel cannabinoid receptor modulators
|
|
AU5932098A
(en)
|
1997-02-04 |
1998-08-25 |
E.I. Du Pont De Nemours And Company |
Fungicidal carboxamides
|
|
CA2470183C
(en)
|
1997-02-21 |
2008-01-29 |
Bayer Aktiengesellschaft |
Intermediates for preparing arylsulphonamides and analogues
|
|
EP0979228A4
(en)
|
1997-03-18 |
2000-05-03 |
Smithkline Beecham Corp |
CANNABINOID RECEPTOR AGONISTS
|
|
FR2761265B1
(fr)
|
1997-03-28 |
1999-07-02 |
Sanofi Sa |
Composition pharmaceutique pour l'administration orale d'un derive du n-piperidino-3-pyrazolecarboxamide, de ses sels et de leurs solvates
|
|
FR2761266B1
(fr)
|
1997-03-28 |
1999-07-02 |
Sanofi Sa |
Composition pharmaceutique formee par granulation humide pour l'administration orale d'un derive du n-piperidino-3- pyrazolecarboxamide, de ses sels et de leurs solvates
|
|
JP4228398B2
(ja)
|
1997-04-23 |
2009-02-25 |
萬有製薬株式会社 |
神経ペプチドｙ受容体拮抗剤
|
|
US6001836A
(en)
|
1997-05-28 |
1999-12-14 |
Bristol-Myers Squibb Company |
Dihydropyridine NPY antagonists: cyanoguanidine derivatives
|
|
SE9702457D0
(sv)
|
1997-06-26 |
1997-06-26 |
Pharmacia & Upjohn Ab |
Screening
|
|
KR20010021696A
(ko)
|
1997-07-11 |
2001-03-15 |
미즈노 마사루 |
퀴놀린 화합물 및 그의 의약용도
|
|
CA2309356C
(en)
|
1997-11-14 |
2010-09-21 |
Amylin Pharmaceuticals, Inc. |
Novel exendin agonist compounds
|
|
EP1068207A1
(en)
|
1998-04-02 |
2001-01-17 |
Neurogen Corporation |
AMINOALKYL SUBSTITUTED 9H-PYRIDINO 2,3-b]INDOLE AND 9H-PYRIMIDINO 4,5-b]INDOLE DERIVATIVES
|
|
TR200100137T2
(tr)
|
1998-04-29 |
2001-05-21 |
Ortho-Mcneil Pharmaceutical, Inc. |
Obesitenin ve başka bozuklukların tedavisinde yararlı nöropeptit Y Y5 reseptörü için ligandlar olarak N-ikameli aminotetralinler.
|
|
US6329395B1
(en)
|
1998-06-08 |
2001-12-11 |
Schering Corporation |
Neuropeptide Y5 receptor antagonists
|
|
AU742425B2
(en)
|
1998-06-11 |
2002-01-03 |
Merck & Co., Inc. |
Spiropiperidine derivatives as melanocortin receptor agonists
|
|
KR20010074784A
(ko)
|
1998-07-29 |
2001-08-09 |
에이지마, 헨리 |
공명 패널형 부재를 구비한 라우드스피커 구동 유닛
|
|
HN1998000027A
(es)
|
1998-08-19 |
1999-06-02 |
Bayer Ip Gmbh |
Arilsulfonamidas y analagos
|
|
DE19837627A1
(de)
|
1998-08-19 |
2000-02-24 |
Bayer Ag |
Neue Aminosäureester von Arylsulfonamiden und Analoga
|
|
US6358951B1
(en)
|
1998-08-21 |
2002-03-19 |
Pfizer Inc. |
Growth hormone secretagogues
|
|
US6337332B1
(en)
|
1998-09-17 |
2002-01-08 |
Pfizer Inc. |
Neuropeptide Y receptor antagonists
|
|
US7358254B2
(en)
*
|
2001-07-13 |
2008-04-15 |
Bristol-Myers Squibb Company |
Method for treating atherosclerosis employing an aP2 inhibitor and combination
|
|
DE69942009D1
(de)
|
1998-10-15 |
2010-03-25 |
Imp Innovations Ltd |
Verbindungen für die behandlung von gewichtsverlust
|
|
EP1129089B1
(en)
|
1998-11-10 |
2005-12-28 |
Merck & Co., Inc. |
Spiro-indolines as y5 receptor antagonists
|
|
ES2161594B1
(es)
|
1998-12-17 |
2003-04-01 |
Servier Lab |
Nuevos derivados de la hidrazida, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
|
|
US6344481B1
(en)
|
1999-03-01 |
2002-02-05 |
Pfizer Inc. |
Thyromimetic antiobesity agents
|
|
SK12992001A3
(sk)
|
1999-03-19 |
2002-03-05 |
Knoll Gmbh |
Použitie zlúčeniny a farmaceutická kompozícia ju obsahujúca
|
|
FR2792314B1
(fr)
|
1999-04-15 |
2001-06-01 |
Adir |
Nouveaux composes aminotriazoles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
US6340683B1
(en)
|
1999-04-22 |
2002-01-22 |
Synaptic Pharmaceutical Corporation |
Selective NPY (Y5) antagonists (triazines)
|
|
JP2002543067A
(ja)
|
1999-04-22 |
2002-12-17 |
シナプティック・ファーマスーティカル・コーポレーション |
選択的なｎｐｙ（ｙ５）のアンタゴニスト
|
|
EP1177172A1
(en)
|
1999-05-05 |
2002-02-06 |
Ortho-McNeil Pharmaceutical, Inc. |
3a,4,5,9b-TETRAHYDRO-1H-BENZ e]INDOL-2-YL AMINE-DERIVED NEUROPEPTIDE Y RECEPTORS LIGANDS USEFUL IN THE TREATMENT OF OBESITY AND OTHER DISORDERS
|
|
EP1177188B1
(en)
|
1999-05-12 |
2005-10-12 |
Ortho-McNeil Pharmaceutical, Inc. |
Pyrazole carboxamides useful for the treatment of obesity and other disorders
|
|
WO2000074679A1
(en)
|
1999-06-04 |
2000-12-14 |
Merck & Co., Inc. |
Substituted piperidines as melanocortin-4 receptor agonists
|
|
AU773892B2
(en)
|
1999-06-30 |
2004-06-10 |
H. Lundbeck A/S |
Selective NPY (Y5) antagonists
|
|
AU6111000A
(en)
*
|
1999-07-22 |
2001-02-13 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of viral helcase
|
|
WO2001007409A1
(en)
|
1999-07-23 |
2001-02-01 |
Astrazeneca Uk Limited |
Carbazole derivatives and their use as neuropeptide y5 receptor ligands
|
|
HUP0202143A3
(en)
|
1999-07-28 |
2003-12-29 |
Ortho Mcneil Pharm Inc |
Amine and amide derivatives as ligands for the neuropeptide y y5 receptor pharmaceutical compositions containing them and their use
|
|
TWI279402B
(en)
|
1999-08-20 |
2007-04-21 |
Banyu Pharma Co Ltd |
Spiro compounds having NPY antagonistic activities and agents containing the same
|
|
PL354675A1
(en)
|
1999-09-30 |
2004-02-09 |
Neurogen Corporation |
Certain alkylene diamine-substituted pyrazolo[1,5,-a]-1,5-pyrimidines and pyrazolo[1,5-a]-1,3,5-triazines
|
|
YU23602A
(sh)
|
1999-09-30 |
2004-09-03 |
Neurogen Corporation |
Amino supstituisani pirazolo /1,5/a/-1,5-pirimidini i pirazolo /1,5-a/-1,3,5-triazini
|
|
AU7738000A
(en)
|
1999-09-30 |
2001-04-30 |
Neurogen Corporation |
Certain alkylene diamine-substituted heterocycles
|
|
DE19949319A1
(de)
|
1999-10-13 |
2001-06-13 |
Ruetgers Vft Ag |
Verfahren zur Herstellung von Arylalkylethern
|
|
SK4732002A3
(en)
|
1999-10-13 |
2002-12-03 |
Pfizer Prod Inc |
Biaryl ether derivatives useful as monoamine reuptake inhibitors
|
|
DE60022386T2
(de)
|
1999-12-16 |
2006-06-22 |
Schering Corp. |
Substituierte imidazole als neuropeptide y y5 rezeptor antagonisten
|
|
AU2001228325A1
(en)
|
2000-02-01 |
2001-08-14 |
Novo-Nordisk A/S |
Use of compounds for the regulation of food intake
|
|
JP2004502642A
(ja)
|
2000-02-11 |
2004-01-29 |
ブリストル−マイヤーズ スクイブ カンパニー |
カンナビノイドレセプターモジュレーター、それらの製造方法、および呼吸系および非呼吸系疾患の処置のためのカンナビノイドレセプターモジュレーターの使用
|
|
GB0004003D0
(en)
|
2000-02-22 |
2000-04-12 |
Knoll Ag |
Therapeutic agents
|
|
EP1264826B1
(en)
|
2000-02-22 |
2005-03-30 |
Banyu Pharmaceutical Co., Ltd. |
Novel imidazoline compounds
|
|
US6531478B2
(en)
|
2000-02-24 |
2003-03-11 |
Cheryl P. Kordik |
Amino pyrazole derivatives useful for the treatment of obesity and other disorders
|
|
FR2805817B1
(fr)
|
2000-03-03 |
2002-04-26 |
Aventis Pharma Sa |
Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation
|
|
FR2805810B1
(fr)
|
2000-03-03 |
2002-04-26 |
Aventis Pharma Sa |
Compositions pharmaceutiques contenant des derives de 3- amino-azetidine, les nouveaux derives et leur preparation
|
|
FR2805818B1
(fr)
|
2000-03-03 |
2002-04-26 |
Aventis Pharma Sa |
Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
|
|
EP1132389A1
(en)
|
2000-03-06 |
2001-09-12 |
Vernalis Research Limited |
New aza-indolyl derivatives for the treatment of obesity
|
|
ES2234840T3
(es)
|
2000-03-14 |
2005-07-01 |
Actelion Pharmaceuticals Ltd. |
Derivados de 1,2,3,4- tetrahidroisoquinolina.
|
|
CA2403686C
(en)
|
2000-03-23 |
2010-01-26 |
Merck & Co., Inc. |
Substituted piperidines as melanocortin receptor agonists
|
|
JP2003527444A
(ja)
|
2000-03-23 |
2003-09-16 |
メルク エンド カムパニー インコーポレーテッド |
メラノコルチン受容体アゴニストとして作用するスピロピペリジン誘導体
|
|
US6600015B2
(en)
|
2000-04-04 |
2003-07-29 |
Hoffmann-La Roche Inc. |
Selective linear peptides with melanocortin-4 receptor (MC4-R) agonist activity
|
|
EP1142886A1
(en)
|
2000-04-07 |
2001-10-10 |
Aventis Pharma Deutschland GmbH |
Percyquinnin, a process for its production and its use as a pharmaceutical
|
|
PT1285651E
(pt)
|
2000-04-28 |
2010-10-21 |
Takeda Pharmaceutical |
Antagonistas da hormona concentradora da melanina
|
|
GB0010757D0
(en)
|
2000-05-05 |
2000-06-28 |
Astrazeneca Ab |
Chemical compounds
|
|
GB0011013D0
(en)
|
2000-05-09 |
2000-06-28 |
Astrazeneca Ab |
Chemical compounds
|
|
WO2001085173A1
(en)
|
2000-05-10 |
2001-11-15 |
Bristol-Myers Squibb Company |
Alkylamine derivatives of dihydropyridine npy antagonists
|
|
US6432960B2
(en)
|
2000-05-10 |
2002-08-13 |
Bristol-Myers Squibb Company |
Squarate derivatives of dihydropyridine NPY antagonists
|
|
US6444675B2
(en)
|
2000-05-10 |
2002-09-03 |
Bristol-Myers Squibb Company |
4-alkyl and 4-cycloalkyl derivatives of dihydropyridine NPY antagonists
|
|
JP2004507456A
(ja)
|
2000-05-11 |
2004-03-11 |
ブリストル−マイヤーズ スクイブ カンパニー |
成長ホルモン分泌促進薬として有用なテトラヒドロイソキノリン類縁体
|
|
EP1283199A4
(en)
|
2000-05-16 |
2003-12-17 |
Takeda Chemical Industries Ltd |
MELANINE CONCENTRATING HORMONE ANTAGONISTS
|
|
EP1286697A2
(en)
|
2000-05-17 |
2003-03-05 |
Eli Lilly And Company |
Method for selectively inhibiting ghrelin action
|
|
US6391881B2
(en)
|
2000-05-19 |
2002-05-21 |
Bristol-Myers Squibb Company |
Thiourea derivatives of dihydropyridine NPY antagonists
|
|
SE0001899D0
(sv)
|
2000-05-22 |
2000-05-22 |
Pharmacia & Upjohn Ab |
New compounds
|
|
EP1289526A4
(en)
|
2000-05-30 |
2005-03-16 |
Merck & Co Inc |
MELANOCORTIN RECEPTOR AGONISTS
|
|
AU6231801A
(en)
|
2000-06-09 |
2001-12-17 |
Aventis Pharma Gmbh |
Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament
|
|
EP1289955B1
(en)
|
2000-06-16 |
2005-04-13 |
Smithkline Beecham Plc |
Piperidines for use as orexin receptor antagonists
|
|
EP1299362A4
(en)
|
2000-07-05 |
2004-11-03 |
Synaptic Pharma Corp |
SELECTIVE RECEPTOR ANTAGONISTS OF MELANINE CONCENTRATING HORMON-1 (MCH1) AND THEIR USE
|
|
WO2002004433A2
(en)
|
2000-07-06 |
2002-01-17 |
Neurogen Corporation |
Melanin concentrating hormone receptor ligands
|
|
GB0019357D0
(en)
|
2000-08-07 |
2000-09-27 |
Melacure Therapeutics Ab |
Novel phenyl guanidines
|
|
MXPA03000436A
(es)
|
2000-07-18 |
2003-06-24 |
Yamanouchi Pharma Co Ltd |
Medicamentos que compreden derivados de dicianopiridina.
|
|
CN1443198A
(zh)
|
2000-07-24 |
2003-09-17 |
阿达纳生物科学有限公司 |
Ghrelin拮抗剂
|
|
WO2002010169A1
(en)
|
2000-07-31 |
2002-02-07 |
F. Hoffmann-La Roche Ag |
Piperazine derivatives
|
|
US6768024B1
(en)
|
2000-08-04 |
2004-07-27 |
Lion Bioscience Ag |
Triamine derivative melanocortin receptor ligands and methods of using same
|
|
GB0019359D0
(en)
|
2000-08-07 |
2000-09-27 |
Melacure Therapeutics Ab |
Novel guanidines
|
|
JP4790969B2
(ja)
|
2000-08-11 |
2011-10-12 |
日本ケミファ株式会社 |
ペルオキシソーム増殖剤応答性受容体δの活性化剤
|
|
EP1320364A1
(en)
|
2000-08-21 |
2003-06-25 |
Gliatech, Inc. |
The use of histamine h3-receptor inverse agonists for the control of appetite and treatment of obesity
|
|
US6680340B2
(en)
|
2000-08-21 |
2004-01-20 |
Merck & Co., Inc. |
Anti-hypercholesterolemic drug combination
|
|
JP2004506687A
(ja)
|
2000-08-23 |
2004-03-04 |
メルク エンド カムパニー インコーポレーテッド |
メラノコルチン受容体作働薬としての置換ピペリジン類
|
|
US6900226B2
(en)
|
2000-09-06 |
2005-05-31 |
Hoffman-La Roche Inc. |
Neuropeptide Y antagonists
|
|
GB0021831D0
(en)
|
2000-09-06 |
2000-10-18 |
Astrazeneca Ab |
Chemical compounds
|
|
MXPA03002263A
(es)
|
2000-09-14 |
2003-06-24 |
Schering Corp |
Antagonistas de receptor de neuropeptido y y5 de urea sustituidos.
|
|
AU2001292480A1
(en)
|
2000-09-26 |
2002-04-08 |
Biovitrum Ab |
Novel pyridazine compounds for the treatment of diabetes
|
|
AU2001292518A1
(en)
|
2000-09-26 |
2002-04-08 |
Biovitrum Ab |
Novel compounds
|
|
JP2002114768A
(ja)
|
2000-10-11 |
2002-04-16 |
Japan Tobacco Inc |
２−（２，５−ジハロゲン−３，４−ジヒドロキシフェニル）アゾール化合物及びそれを含有してなる医薬組成物
|
|
CZ20031029A3
(cs)
|
2000-10-13 |
2003-09-17 |
Eli Lilly And Company |
Substituované dipeptidy jako sekretagogy růstového hormonu
|
|
WO2002044152A1
(en)
|
2000-10-16 |
2002-06-06 |
F. Hoffmann-La Roche Ag |
Indoline derivatives and their use as 5-ht2 receptor ligands
|
|
WO2002032897A1
(en)
|
2000-10-20 |
2002-04-25 |
Pfizer Products Inc. |
Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists
|
|
WO2002036596A2
(en)
|
2000-11-03 |
2002-05-10 |
Wyeth |
CYCLOALKYL[b][1,4]DIAZEPINO[6,7,1-hi]INDOLES AND DERIVATIVES
|
|
AU2426602A
(en)
|
2000-11-20 |
2002-05-27 |
Biovitrum Ab |
Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5ht-2 receptor
|
|
JP4204315B2
(ja)
|
2000-11-20 |
2009-01-07 |
ビオヴィトルム・アクチボラゲット（プブリクト） |
セロトニン５−ｈｔ２レセプターのアンタゴニストとしてのピペラジニルピラジン化合物
|
|
EP1341774B1
(en)
|
2000-12-06 |
2006-02-01 |
F. Hoffmann-La Roche Ag |
Fused heteroaromatic glucokinase activators
|
|
JP2004520299A
(ja)
|
2000-12-12 |
2004-07-08 |
ニューロジェン・コーポレーション |
スピロ［イソベンゾフラン−１，４’−ピペリジン］−３−オン類及び３ｈ−スピロイソベンゾフラン−１，４’−ピペリジン類
|
|
US6482951B2
(en)
|
2000-12-13 |
2002-11-19 |
Hoffmann-La Roche Inc. |
Isoindolin-1-one glucokinase activators
|
|
GB0030710D0
(en)
|
2000-12-15 |
2001-01-31 |
Hoffmann La Roche |
Piperazine derivatives
|
|
SG138463A1
(en)
|
2000-12-21 |
2008-01-28 |
Schering Corp |
Heteroaryl urea neuropeptide y y5 receptor antagonists
|
|
HUP0302582A2
(hu)
|
2000-12-22 |
2003-12-29 |
Schering Corp. |
Piperidin MCH antagonisták, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk elhízás kezelésére
|
|
WO2002051232A2
(en)
|
2000-12-27 |
2002-07-04 |
Actelion Pharmaceuticals Ltd. |
Novel benzazepines and related heterocyclic derivatives
|
|
BR0116605A
(pt)
|
2000-12-27 |
2003-09-30 |
Hoffmann La Roche |
Composto, processo para a preparação de um composto, composição farmacêutica que compreende o mesmo, sua utilização e processo para o tratamento e profilaxia de distúrbios do sistema nervoso central, distúrbios cardiovasculares, distúrbios gastrintestinais e apnéia do sono
|
|
JP2004523530A
(ja)
|
2001-01-23 |
2004-08-05 |
イーライ・リリー・アンド・カンパニー |
メラノコルチン受容体アゴニストとしてのピペラジンおよびピペリジン誘導体
|
|
CA2433025A1
(en)
|
2001-01-23 |
2002-08-01 |
Chaoyu Xie |
Substituted piperidines/piperazines as melanocortin receptor agonists
|
|
EP1358163A1
(en)
|
2001-01-23 |
2003-11-05 |
Eli Lilly And Company |
Melanocortin receptor agonists
|
|
BR0206831A
(pt)
|
2001-02-02 |
2004-07-06 |
Takeda Chemical Industries Ltd |
Composto, cristal, agente farmacêutico, agentes para profilaxia ou tratamento de diabetes, de complicações diabéticas, de tolerância prejudicada à glucose e de obesidade, inibidor de peptidase, uso de um composto, e, método de produção de um composto
|
|
JP4316238B2
(ja)
|
2001-02-28 |
2009-08-19 |
メルク エンド カムパニー インコーポレーテッド |
メラノコルチン−４受容体作動薬としてのアシル化ピペリジン誘導体
|
|
ATE341327T1
(de)
|
2001-02-28 |
2006-10-15 |
Merck & Co Inc |
Acylierte piperidin-derivate als melanocortin-4- rezeptor-agonisten
|
|
CA2439152C
(en)
|
2001-02-28 |
2008-06-17 |
Merck & Co., Inc. |
Acylated piperidine derivatives as melanocortin-4 receptor agonists
|
|
CZ2003698A3
(cs)
|
2001-03-22 |
2003-06-18 |
Solvay Pharmaceuticals B. V. |
4,5-Dihydro-1H-pyrazolové deriváty mající CB1-antagonistickou účinnost
|
|
WO2001074782A1
(en)
|
2001-03-29 |
2001-10-11 |
Molecular Design International, Inc. |
β3-ADRENORECEPTOR AGONISTS, AGONIST COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME
|
|
US6573287B2
(en)
|
2001-04-12 |
2003-06-03 |
Bristo-Myers Squibb Company |
2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase IV and method
|
|
FR2824825B1
(fr)
|
2001-05-15 |
2005-05-06 |
Servier Lab |
Nouveaux derives d'alpha-amino-acides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
AU2002344820B2
(en)
|
2001-06-20 |
2006-12-14 |
Merck & Co., Inc. |
Dipeptidyl peptidase inhibitors for the treatment of diabetes
|
|
CA2450475A1
(en)
|
2001-06-20 |
2003-01-03 |
Linda Brockunier |
Dipeptidyl peptidase inhibitors for the treatment of diabetes
|
|
GB0115517D0
(en)
|
2001-06-25 |
2001-08-15 |
Ferring Bv |
Novel antidiabetic agents
|
|
US6684968B2
(en)
|
2001-06-25 |
2004-02-03 |
Kennametal Inc. |
Roof bit body and insert assembly
|
|
ATE380175T1
(de)
|
2001-06-27 |
2007-12-15 |
Smithkline Beecham Corp |
Pyrrolidine als dipeptidyl peptidase inhibitoren
|
|
JP3909056B2
(ja)
|
2001-06-27 |
2007-04-25 |
スミスクライン ビーチャム コーポレーション |
ジペプチジルペプチダーゼ阻害剤としてのフルオロピロリジン類
|
|
ATE370943T1
(de)
|
2001-06-27 |
2007-09-15 |
Smithkline Beecham Corp |
Fluoropyrrolidine als dipeptidyl-peptidase inhibitoren
|
|
RU2299066C2
(ru)
|
2001-06-27 |
2007-05-20 |
Пробиодруг Аг |
Новые ингибиторы дипептидилпептидазы iv и их применение в качестве противораковых агентов
|
|
EP1404675B1
(en)
|
2001-07-03 |
2008-03-12 |
Novo Nordisk A/S |
Dpp-iv-inhibiting purine derivatives for the treatment of diabetes
|
|
WO2003007949A1
(en)
|
2001-07-18 |
2003-01-30 |
Merck & Co., Inc. |
Bridged piperidine derivatives as melanocortin receptor agonists
|
|
AU2002319627A1
(en)
|
2001-07-20 |
2003-03-03 |
Merck And Co., Inc. |
Substituted imidazoles as cannabinoid receptor modulators
|
|
US6977264B2
(en)
|
2001-07-25 |
2005-12-20 |
Amgen Inc. |
Substituted piperidines and methods of use
|
|
US6915444B2
(en)
|
2001-09-12 |
2005-07-05 |
Rockwell Automation Technologies, Inc. |
Network independent safety protocol for industrial controller using data manipulation techniques
|
|
ES2320979T3
(es)
|
2001-09-24 |
2009-06-01 |
Imperial Innovations Limited |
Pyy-36 para la reduccion o prevencion de la obesidad.
|
|
EP1585956A4
(en)
|
2001-09-24 |
2009-10-21 |
Univ Oregon Health & Science |
EVALUATION OF NEURONS IN THE NUCLEUS ARCUATUS FOR SCREENING ON THE ESSENTIAL CHANGING SUBSTANCES
|
|
JP4733922B2
(ja)
|
2002-01-10 |
2011-07-27 |
インペリアル・イノベ−ションズ・リミテッド |
摂食行動の修正
|
|
JP4330353B2
(ja)
|
2003-02-21 |
2009-09-16 |
株式会社静岡カフェイン工業所 |
ピリミジン誘導体
|
|
JP5201817B2
(ja)
|
2005-10-28 |
2013-06-05 |
大塚製薬株式会社 |
医薬組成物
|
|
AU2007323335A1
(en)
|
2006-11-23 |
2008-05-29 |
Novartis Ag |
Pyrimidines and their use as CXCR2 receptor antagonists
|
|
PE20120640A1
(es)
|
2009-07-02 |
2012-06-09 |
Sanofi Sa |
Nuevos derivados de (6-oxo-1,6-dihidro-pirimidin-2-il)-amida, su preparacion y su utilizacion farmaceutica como inhibidores de fosforilacion de akt (pkb)
|
|
WO2011006158A2
(en)
|
2009-07-10 |
2011-01-13 |
University Of Maryland, Baltimore |
Targeting nad biosynthesis in bacterial pathogens
|
|
UA112284C2
(uk)
|
2009-08-07 |
2016-08-25 |
ДАУ АГРОСАЙЄНСІЗ ЕлЕлСі |
Похідні 5-фторпіримідинону
|
|
JP2013226269A
(ja)
|
2012-04-26 |
2013-11-07 |
Maruhon Industry Co Ltd |
パチンコ機
|
|
CN103864699B
(zh)
|
2012-12-11 |
2016-04-06 |
北京大学 |
具有抗HBV病毒且兼具抗HIV和HCV病毒作用的新一类非核苷S-DABOs嘧啶酮衍生物的制备和应用
|
|
CA2942058A1
(en)
|
2014-03-10 |
2015-09-17 |
The Regents Of The University Of Michigan |
Methods and compositions for inhibiting rho/mrtf-mediated diseases and conditions
|
|
BR112017003745A2
(pt)
*
|
2014-08-29 |
2017-12-05 |
Tes Pharma S R L |
inibidores de semialdeído descarboxilase de ácido alfa-amino-beta-carboximucônico
|
|
AU2017342083A1
(en)
*
|
2016-10-14 |
2019-04-11 |
Tes Pharma S.R.L. |
Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase
|
|
US20190367457A1
(en)
|
2016-12-30 |
2019-12-05 |
Mitobridge, Inc. |
Oxopyridine derivatives useful as aminocarboxymuconate semialdehyde decarboxylase (acmsd) inhibitors
|
|
EP3883930A1
(en)
|
2018-11-20 |
2021-09-29 |
Tes Pharma S.r.l. |
Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase
|